The Immune System Study

Currently Recruiting

3 Dec to 7 Dec 2025

Up to $5,950

This study will investigate a new drug designed to treat Autoimmune diseases.

Apply now Speak with us

Join our clinical trial

This study will investigate a new drug designed to treat Autoimmune diseases. Autoimmune diseases occur when the immune system mistakenly attacks healthy cells, with more than 80 different conditions such as myasthenia gravis, rheumatoid arthritis, multiple sclerosis, lupus, and psoriasis. In Australia, they affect around 1 in 20 people, making them one of the most common groups of chronic illnesses. These conditions can range from manageable to severe or life-threatening, placing a significant health burden on the community. 

This is  the first time this investigational treatment will be given to healthy volunteers. The investigational treatment has previously been tested in other studies involving patients with cancer or various autoimmune conditions. This study will test different ways to administer the investigational treatment. The study has been carefully designed with strict safety protocols and has been approved by an independent ethics committee. 

Before joining, you’ll receive detailed information about the study, meet with a doctor, and have the chance to ask any questions. 

Nucleus Network - Image

Why participate?

  • Contribute to Research that supports communities across the globe. 
  • Help Make Treatments More Inclusive and Effective 
  • Be the Reason Better Treatments Move Forward 

Taking part in this study offers access to specialist medical care and close monitoring, while also contributing to important research that may improve treatment options in the future. Participants are paid for their time and commitment and play an active role in shaping better outcomes for people living with autoimmune conditions. 

Trial details

Study medication

Administered as an intravenous (IV) infusion, whereby the study drug is administered into a vein in your arm

Ethics

An independent ethics committee has approved this clinical trial. 

Additional eligibility

  • Weigh between 55kg and 100kg. 
  • No tobacco or nicotine use during your stay 
  • No history of chronic medication use (as discussed with our medical team) 
  • No serious medical conditions  
  • Not pregnant or breastfeeding 
  • Willing to follow contraception guidelines 
  • Able to attend all study visits and follow instructions 

Study duration

4-night in-clinic stay and 7 follow-up visits

Are you a match?

Age

18 - 65 years old

Remuneration

Up to $5,950 *with screening reimbursement. Please see T&Cs.

Gender

Male or Female

BMI

BMI 18 - 30 kg/m2

Commitment

4 nights, 7 clinic visits

Register Your Interest

This form takes around 3–5 minutes to complete. Your information will remain confidential and is used only to assess your eligibility for current or future research studies.
Step 1 of 3
Contact Information




The phone number you have entered does not appear to be a valid active Australian phone number. Please check your details and enter a valid Australian phone number starting with +61

Nucleus Network does not currently conduct clinical trials in your state. If you would like to receive study information should this situation change, please complete and submit this form.
Personal Information

This includes registering your interest with the Centre for Clinical Studies, Q-Pharm or Nucleus Network

Please call us on 1800 243 733 or schedule a call.


What is your date of birth?
Day Month Year

You need to be at least 18 years old to participate in clinical trials.


cm

kg





















Step 2 of 3
Medical History

We regularly have studies that allow participants who are (social) smokers.

We define an allergy as severe if symptoms include mouth/throat/face swelling, shortness of breath or a whole-body rash, or if it required hospitalisation

We regularly have studies that allow for/require participants with asthma.



We regularly have studies that allow for/require participants with medical conditions.

Medications & Contraception Requirements

We regularly have studies that allow participants with depression that is well-managed on a stable dose of medication.

If the only prescription medication you currently use is hormonal contraception and/or Ventolin, please select No above. We regularly have studies that allow for participants who take a stable dose of prescription medication.


  • Abstinence from sex with anyone of the opposite sex for at least 2 months
  • Using a condom + your female sexual partner(s) using a separate form of birth control
  • You or your sexual partner(s) had a vasectomy/hysterectomy
  • Your sexual partner(s) are post-menopausal


Only you taking birth control or your partner(s) using a condom is not an acceptable option, but using both together is. The morning after pill is not an acceptable form of birth control.

  • Abstinence, by choice, from sex with anyone of the opposite sex for the last 2 months + remaining abstinent for at least 2 months after study participation
  • You using birth control + your male sexual partner(s) using a condom
  • You or your sexual partner(s) had a hysterectomy/vasectomy
  • You are post-menopausal



Step 3 of 3
Study Preferences

While longer studies generally have a higher reimbursement, there are also studies with multiple short stays that have high reimbursements.
Referral Information



Consent to Information Use and Future Contact